In Vitro Inhibition of Borrelia burgdorferi Growth by Antibodies

Journal of Infectious Diseases

Volumn 167, Issue 1, 1993, Pages 165-172

  Šadžiene, Ariadna ^a,b   Thompson, Patricia A ^a,b   Barbour, Alan G ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Research Institute of Experimental and Clinical Medicine   (Lithuania)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISERUM; BACTERIUM ANTIBODY; COMPLEMENT; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; OUTER MEMBRANE PROTEIN;

AGGLUTINATION TEST; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL GROWTH; BORRELIA BURGDORFERI; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GROWTH INHIBITION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; RAT;

AGGLUTINATION TESTS; ANIMAL; ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL; BORRELIA BURGDORFERI GROUP; COMPLEMENT; FEMALE; HUMAN; IMMUNE SERA; MICE; MICE, INBRED BALB C; RATS; RATS, INBRED LEW; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027509237     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/167.1.165     Document Type: Article

References (44)

1. Barbour AG. Laboratory aspects of Lyme borreliosis. Clin Microbiol Rev 1988;1:399-414.
2. Barbour AG. Burgdorfer W. Grunwaldt E. Steere Ac Antibodies of patients with Lyme disease to components of the Ixodes dammini spirochete. J Clin Invest 1983;72:504-15.
3. Craft JE, Fischer OK, Shimamoto GT, Steere AC, Antigens of Borrelia burgdorferi recognized during Lyme disease. Appearance of a new immunoglobulin Mresponse and expansion oftheimmunoglobulin G late in the illness. J Clin Invest 1986;78:934-9.
4. Wilske B, Preac MY, Schierz G, Kuhbeck R, Barbour AG, Kramer M. Antigenic variability of Borrelia burgdorferi. Ann NY Acad Sci 1988;539:126-43.
5. Kochi SK. Johnson RC, Role ofimmunoglobulin Gin killing ofBorrelia burgdorferi bythe classical complement pathway. Infect Immun 1987;56:314-21.
6. Kochi SK, Johnson RC, Dalmasso AP. Complement-mediated killing of the Lyme disease spirochete Borrelia burgdorferi. J Immunol 1991; 146:3964-70.
7. Schmitz JL, Schell RF, Lovrich SO, Callister SM, Coe JE. Characterization ofprotective antibody response toBorrelia burgdorferi inexperimentally infected LSH hamsters. Infect Immun 1991;59:1916-21.
8. Artsob H, Huibner S. Complement fixation test for the diagnosis of Lyme disease. J Clin Microbiol 1990;28:637-8.
9. Callister SM, Schell RF, Lovrich SD. Lyme disease assay which detects killed Borrelia burgdorferi. J Clin Microbiol 1991;29: 1773-6.
10. Johnson RC, Kodner C, Russell M. Passive immunization ofhamsters against experimental infection with Lyme disease spirochete. Infect Immun 1986;53:713-4.
11. Schmitz JL, Schell RF, Hejka AG, England OM. Passive immunization prevents induction ofLyme arthritis inLSH hamsters. Infect Immun 1990;58:144-8.
12. Schaible UE, Kramer MO, Eichmann K, Modolell M, Museteanu C, Simon MM. Monoclonal antibodies specific for the outer surface protein A(OspA) ofBorrelia burgdorferi prevent Lyme borreliosis in severe combined immunodeficiency (scid) mice. Proc Nat! Acad Sci USA 1990;87:3768-72.
13. Simon MM, Schaible UE, Wallich R, Kramer MD. A mouse model for Borrelia burgdorferi infection: approach to a vaccine against Lyme disease. Immunol Today 1991;12:11-6.
14. Simon MM, Schaible UE, Kramer MD, et al. Recombinant outer surface protein from Borrelia burgdorftri induces antibodies protective against spirochetal infection in mice. J Infect Dis 1991; 164:123-32.
15. Fikrig E, Barthold SW, Kantor FS, Flavell RA. Protection of mice against the Lyme disease agent by immunizing with recombinant OspA. Science 1990;250:553.
16. Barbour AG, Stoenner HG. Antigenic variation ofBorrelia hermsii. In: Herskowitz I, Simon M, eds. Genome rearrangement. UCLA symposia on molecular and cellular biology. New series. Vol 20. New York: Alan R Liss, 1985: 123-35.
17. Burgdorfer W, Barbour AG, Hayes SF, Benach JJ., Brunwaldt E, Davis JP. Lyme disease-a tick-borne spirochetosis? Science 1982;216: 1317-9.
18. Barbour AG, Tessier SL, Todd WJ. Lyme disease spirochetes and Ixodes tick spirochetes share a common surface antigen determinant defined by a monoclonal antibody. Infect Immun 1983;41:795-804.
19. Steere AC, Grodzicki RL, Kornblatt AN, et al. The spirochetal etiology of Lyme disease. N Engl J Med 1983;308:733-40.
20. Huppertz HI, Sticht-Groh V, Schwan T. Borderline antibody response in initial stages oflymphocytic meningitis does not rule out borreliosis. Lancet 1986;2: 1986-7.
21. Marconi RT, Garon CF. Phylogenetic analysis of the genus Borrelia: a comparison of North American and European isolates of Borrelia burgdorferi. J Bacteriol 1992;174:241-4.
22. Barbour AG. Plasmid analysis of Borrelia burgdorferi, the Lyme disease agent. J Clin Microbiol 1987;26:475-8.
23. Bundoc VG, Barbour AG. Clonal polymorphisms of outer membrane protein OspB of Borrelia burgdorferi. Infect Immun 1989;57:273-341.
24. Barthold SW, Moody KD, Beck OS. Susceptibility oflaboratory rats to isolates of Borrelia burgdorferi from different geographic areas. Am J Trop Med Hyg 1990;42:596-600.
25. Barbour AG. Isolation and cultivation of Lyme disease spirochetes. Yale J Biol Med 1984;57:521-5.
26. Barbour AG, Heiland RA, Howe TR. Heterogeneity of major proteins in Lyme disease borreliae; a molecular analysis of North American and European isolates. J Infect Dis 1985; 152:478-84.
27. Barbour AG, Tessier SL, Hayes SF. Variation in a major surface protein of Lyme disease spirochetes. Infect Immun 1984;45:94-100.
28. Centers for Disease Control. Lyme disease surveillance-United States, 1989-1990. JAMA 1991;266:470-1.
29. Šadžiene A, Thomas DO, Bundoc VG, Holt SH, Barbour AG. A flagella-less mutant of Borrelia burgdorftri. J Clin Invest 1991;88:82-92.
30. Sikkema WD. An Fe-binding protein. American Biotechnology Laboratory 1989;7(4a):42.
31. Barbour AG, Tessier SL, Stoenner HG. Variable major proteins of Borrelia hermsii. J Exp Med 1982;156:1312-24.
32. Barbour AG, Hayes SF, Heiland RA, Schrumpf ME, Tessier SL. A Borrelia-specific MAb binds to flagellar epitope. Infect Immun 1986;52:549-54.
33. Simpson WI, Schrumpf ME, Schwan TG. Reactivity of human Lyme borreliosis sera with 39-kilodalton antigen specific to Borrelia burgdorferi. J Clin Microbiol 1990;28:1329-37.
34. Barbour AG. Immunochemical analysis of Lyme disease spirochetes. Yale J Biol Med 1984;57:581-6.
35. Dever LL, Jorgensen IH, Barbour AG. In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: a microdilution MIC method and time-kill studies. J Clin Microbiol 1992;30:2692-7.
36. Šadžiene A, Rosa PA, Thompson PA, Hogan OM, Barbour AG. Antibody-resistant mutants of Borrelia burgdorferi: in vitro selection and characterization. J Exp Med 1992; 176:799-809.
37. Luft BI, liang W, Munoz P, Dattwyler RI, Gorevic PD. Biochemical and immunochemical characterization of the surface proteins of Borrelia burgdorferi. Infect Immun 1989;57:3637-45.
38. Lefebvre RB, Pemg GC, Johnson RC. The 83-kilodalton antigen of Borrelia burgdorferi which stimulates immunoglobulin M (IgM) responses in infected hosts is expressed by a chromosomal gene. J Clin Microbiol 1990;28: 1673-5.
39. Felsenfeld O. Borrelia. St. Louis: Warren H Green, 1971.
40. Gabritschewski G. Les bases de la serotherapie de la fievre recurrente. Ann Inst Pasteur 1896; 10:629-59.
41. Novy FG, Knapp RE. Studies on Spirillum obermeieri and related organisms. J Infect Dis 1906;3:291-393.
42. Meleney HE. Relapse phenomena of Spironema reccurentis. J Exp Med 1928; 1928:65-82.
43. Toyoda H. Ober die Serumfestigkeit der Recurrensspirochaeten und die Heilung der durch sie verursachten Kranheit. Kitasato Arch Exp Med 1920;4:40-88.
44. Coleman JL., Rogers RC, Benach JL. Selection of an escape variant of Borrelia burgdorferi by use of bactericidal monoclonal antibodies to OspB. Infect Immun 1992;60: 3098-104.